Skip to content
2000
Volume 17, Issue 6
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Hyaluronic acid (HA) is a relatively new polymer for the construction of drug delivery systems. CD44 and the receptor for HA-mediated motility play a key role in vivo for the receptormediated endocytosis of HA. Cellular uptake and the efficiency of tumor-targeted drug delivery are supposed to increase through utilizing HA as drug carriers. Currently, HA has provided a promising platform to physically encapsulate or chemically conjugate with various drugs. In this review, we presented the most latest advances in HA-based drug delivery systems and some forward-looking ideas are discussed.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/1389450116666150531155200
2016-05-01
2025-10-27
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/1389450116666150531155200
Loading

  • Article Type:
    Research Article
Keyword(s): CD44; chemical modification; conjugates; derivatives; hyaluronic acid; nanocarriers
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test